Can gabapentin be used to treat chronic cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Gabapentin for Chronic Cough

Gabapentin is an effective treatment option for unexplained chronic cough (cough persisting >8 weeks despite appropriate investigation and treatment), with demonstrated improvements in quality of life, but should only be used after ruling out treatable causes and requires careful discussion of side effects with reassessment at 6 months. 1

When to Use Gabapentin

The 2016 CHEST guidelines provide clear criteria for gabapentin use 1:

  • Define unexplained chronic cough first: Cough lasting >8 weeks that remains unexplained after investigation and supervised therapeutic trials according to best-practice guidelines
  • Complete proper workup: Patients must undergo objective testing for bronchial hyperresponsiveness and eosinophilic bronchitis, or a therapeutic corticosteroid trial
  • Rule out specific causes: Do NOT use inhaled corticosteroids if tests for bronchial hyperresponsiveness and eosinophilia are negative 1

Evidence for Efficacy

Gabapentin has robust support for treating refractory chronic cough:

  • Quality of life improvement: A landmark RCT showed gabapentin significantly improved cough-specific quality of life (Leicester Cough Questionnaire score difference of 1.80, p=0.004) with a number needed to treat of 3.58 2
  • Cough frequency reduction: Meta-analysis demonstrated reduction in 24-hour cough frequency (mean difference -7.91) 3
  • Mechanism: Works through neuromodulation of enhanced neural sensitization, a key component of unexplained cough 1

The evidence shows gabapentin is more effective than placebo and demonstrates the most substantial improvements among neuromodulators studied 3.

Dosing Protocol

Start low and titrate up 1:

  • Begin at 300 mg once daily
  • Add additional doses each day as tolerated
  • Maximum tolerable dose: 1,800 mg daily in two divided doses
  • Optimal treatment duration: 12 weeks for maximal effect 3

Side Effects and Monitoring

Common adverse effects (occurred in 31% of patients) 1:

  • Confusion, dizziness, dry mouth, fatigue, nausea
  • Less common: blurred vision, headache, memory loss

Critical safety considerations 4:

  • Discuss risk-benefit profile before initiating treatment
  • Mandatory reassessment at 6 months before continuing 1
  • Monitor for suicidal thoughts (occurs in ~1 in 500 patients on antiepileptic drugs)
  • Can be removed by hemodialysis if needed in overdose

Treatment Algorithm

Step 1: Confirm chronic cough (>8 weeks duration)

Step 2: Complete diagnostic workup:

  • Test for bronchial hyperresponsiveness
  • Check for eosinophilic bronchitis (sputum eosinophils, exhaled nitric oxide)
  • Rule out GERD with appropriate testing

Step 3: Try first-line treatments based on identified causes

Step 4: If cough persists (now "unexplained chronic cough"):

  • Consider multimodality speech pathology therapy first 1
  • Initiate gabapentin with informed consent about side effects
  • Titrate from 300 mg daily to maximum 1,800 mg daily in divided doses

Step 5: Reassess at 6 months:

  • If successful: wean to lowest cough-controlling dose (68.3% of practitioners) or taper off completely (24.4%) 5
  • If unsuccessful: consider switching to another neuromodulator (amitriptyline) or superior laryngeal nerve block 5
  • If cough recurs after successful treatment: reinitiate the same dose that previously worked 5

Important Caveats

Do NOT use gabapentin if:

  • Bronchial hyperresponsiveness or eosinophilia testing is positive (use inhaled corticosteroids instead) 1
  • Patient has not completed appropriate diagnostic workup
  • GERD workup is negative (don't add proton pump inhibitors) 1

Practical considerations:

  • Gabapentin is preferred over morphine (which failed to gain guideline approval due to safety concerns) 1
  • Among laryngologists, gabapentin (45.1%) and amitriptyline (39.0%) are the preferred first-line neuromodulators 5
  • Patients with vocal fold motion asymmetry on videostroboscopy have higher odds of responding to gabapentin (94% vs 56%) 6

The CHEST Expert Panel emphasizes that because health-related quality of life can be severely impacted by unexplained chronic cough, the potential benefits of gabapentin outweigh the side effects in appropriately selected patients 1.

Related Questions

Can gabapentin be taken in the morning and pregabalin in the evening for a patient with neurogenic chronic cough?
What is the recommended gabapentin dosing schedule for managing refractory dry cough?
For a patient with chronic cough, negative Bravo pH monitoring, normal pulmonary function tests, completed speech‑therapy, on gabapentin (causing thick saliva), and concerned about prebiotic use, what does a negative barium swallow indicate and how should the management plan be adjusted?
Is gabapentin appropriate for treating a chronic refractory cough in an adult patient?
What is the appropriate management for a patient whose cough persists despite supplemental oxygen and nebulized bronchodilator therapy?
What are the common triggers and recommended treatment options for psychogenic non‑epileptic seizures (PNES)?
What is the recommended treatment and dosing for acute cystitis in a man?
What does a significant level of Streptococcus pneumoniae in a clinical specimen indicate and what is the appropriate treatment?
In a 68-year-old man with a rapidly enlarging, ulcerated lesion on his sun-exposed right forearm and a history of frequent outdoor fishing, what are the likely differential diagnoses?
What is the differential diagnosis and urgent management for a patient with headache, left-sided facial and maxillary pain, and left lower extremity pain and numbness?
What characteristic finding is typical of the most likely diagnosis for a 0.5‑cm, painless, long‑standing lesion behind the right auricular lobule in a 71‑year‑old patient with no prior history of skin cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.